Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Non-arteritic Ischemic Optic Neuropathy
Who is this study for? Patients with Eye Diseases
What treatments are being studied? AlloRx
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
This trial will study the safety and efficacy of intravenous and sub-tenon delivery of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of non-arteritic ischemic optic neuropathy
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Diagnosis of NAION (non-arteritic ischemic optic neuropathy)
• Understanding and willingness to sign a written informed consent document
Locations
Other Locations
Antigua and Barbuda
Medical Surgical Associates Center
RECRUITING
St. John's
Argentina
Center for Investigation in Tissue Engineering and Cellular Therapy
RECRUITING
Buenos Aires
Time Frame
Start Date: 2022-02-01
Estimated Completion Date: 2026-01
Participants
Target number of participants: 20
Treatments
Experimental: Treatment Group (AlloRx)
intravenous and sub-tenon delivery (total dose of 100 million cells)
Related Therapeutic Areas
Sponsors
Leads: The Foundation for Orthopaedics and Regenerative Medicine